<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>IIT Bombay&#039;s TIH Concludes ATMAN 3.0; 6 Health-tech Startups to Receive Upto INR 6-crore Cumulative Seed Funding</title>
    <link>https://www.taxtmi.com/news?id=67245</link>
    <description>TIH IIT Bombay&#039;s ATMAN 3.0 accelerator recommended cumulative seed funding of up to INR 6 crore for six HealthTech startups (up to INR 1 crore each, subject to evaluation) after a competitive selection and mentoring process. The programme paired funding recommendations with technology validation, regulatory guidance, investor-readiness coaching and industry connections to strengthen commercialization potential. Demo Day featured investor and stakeholder engagement and sector discussions on investment trends and evolving regulatory frameworks, highlighting regulatory alignment and clinical-economic impact as key conditions for deployment and follow-on investment.</description>
    <language>en-us</language>
    <pubDate>Tue, 13 Jan 2026 16:46:03 +0530</pubDate>
    <lastBuildDate>Tue, 13 Jan 2026 16:46:03 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=878160" rel="self" type="application/rss+xml"/>
    <item>
      <title>IIT Bombay&#039;s TIH Concludes ATMAN 3.0; 6 Health-tech Startups to Receive Upto INR 6-crore Cumulative Seed Funding</title>
      <link>https://www.taxtmi.com/news?id=67245</link>
      <description>TIH IIT Bombay&#039;s ATMAN 3.0 accelerator recommended cumulative seed funding of up to INR 6 crore for six HealthTech startups (up to INR 1 crore each, subject to evaluation) after a competitive selection and mentoring process. The programme paired funding recommendations with technology validation, regulatory guidance, investor-readiness coaching and industry connections to strengthen commercialization potential. Demo Day featured investor and stakeholder engagement and sector discussions on investment trends and evolving regulatory frameworks, highlighting regulatory alignment and clinical-economic impact as key conditions for deployment and follow-on investment.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Tue, 13 Jan 2026 16:46:03 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=67245</guid>
    </item>
  </channel>
</rss>